AVNS: Avanos Medical Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Avanos Medical Inc (AVNS).
$731.64M Market Cap.
AVNS Market Cap. (MRY)
AVNS Shares Outstanding (MRY)
AVNS Assets (MRY)
Total Assets
$1.15B
Total Liabilities
$325.70M
Total Investments
$0
AVNS Income (MRY)
Revenue
$687.80M
Net Income
-$392.10M
Operating Expense
$781.40M
AVNS Cash Flow (MRY)
CF Operations
$100.70M
CF Investing
-$27.50M
CF Financing
-$49.10M
AVNS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $1,154,200,000 (-31.80%) | $1,692,400,000 (-5.29%) | $1,786,900,000 (11.43%) | $1,603,600,000 (-4.14%) |
Assets Current | $393,400,000 (-19.22%) | $487,000,000 (-21.97%) | $624,100,000 (45.95%) | $427,600,000 (-8.48%) |
Assets Non-Current | $760,800,000 (-36.88%) | $1,205,400,000 (3.66%) | $1,162,800,000 (-1.12%) | $1,176,000,000 (-2.46%) |
Goodwill & Intangible Assets | $567,900,000 (-45.16%) | $1,035,600,000 (4.13%) | $994,500,000 (5.48%) | $942,800,000 (-1.81%) |
Shareholders Equity | $828,500,000 (-32.99%) | $1,236,300,000 (-4.25%) | $1,291,200,000 (1.62%) | $1,270,600,000 (1.12%) |
Property Plant & Equipment Net | $144,800,000 (0.56%) | $144,000,000 (-1.44%) | $146,100,000 (-29.32%) | $206,700,000 (-7.56%) |
Cash & Equivalents | $107,700,000 (22.81%) | $87,700,000 (-31.32%) | $127,700,000 (7.76%) | $118,500,000 (6.28%) |
Accumulated Other Comprehensive Income | -$44,600,000 (-65.19%) | -$27,000,000 (24.58%) | -$35,800,000 (-5.92%) | -$33,800,000 (-20.28%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $138,800,000 (-14.95%) | $163,200,000 (23.36%) | $132,300,000 (-16.95%) | $159,300,000 (-5.68%) |
Trade & Non-Trade Receivables | $132,800,000 (-7.00%) | $142,800,000 (-14.95%) | $167,900,000 (27.97%) | $131,200,000 (20.81%) |
Trade & Non-Trade Payables | $54,300,000 (-3.55%) | $56,300,000 (-17.08%) | $67,900,000 (20.39%) | $56,400,000 (-16.57%) |
Accumulated Retained Earnings (Deficit) | -$707,000,000 (-124.52%) | -$314,900,000 (-24.42%) | -$253,100,000 (16.63%) | -$303,600,000 (3.77%) |
Tax Assets | $24,900,000 (283.08%) | $6,500,000 (41.30%) | $4,600,000 (-54.00%) | $10,000,000 (-85.57%) |
Tax Liabilities | $5,500,000 (-76.89%) | $23,800,000 (-6.30%) | $25,400,000 (113.45%) | $11,900,000 (108.77%) |
Total Debt | $170,200,000 (-18.60%) | $209,100,000 (-24.51%) | $277,000,000 (47.73%) | $187,500,000 (-24.64%) |
Debt Current | $20,300,000 (-5.14%) | $21,400,000 (17.58%) | $18,200,000 (23.81%) | $14,700,000 (-5.16%) |
Debt Non-Current | $149,900,000 (-20.14%) | $187,700,000 (-27.47%) | $258,800,000 (49.77%) | $172,800,000 (-25.93%) |
Total Liabilities | $325,700,000 (-28.59%) | $456,100,000 (-7.99%) | $495,700,000 (48.86%) | $333,000,000 (-20.01%) |
Liabilities Current | $165,900,000 (-29.28%) | $234,600,000 (22.83%) | $191,000,000 (37.21%) | $139,200,000 (-16.30%) |
Liabilities Non-Current | $159,800,000 (-27.86%) | $221,500,000 (-27.31%) | $304,700,000 (57.22%) | $193,800,000 (-22.48%) |
AVNS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $687,800,000 (2.15%) | $673,300,000 (-1.58%) | $684,100,000 (16.54%) | $587,000,000 (-17.88%) |
Cost of Revenue | $306,500,000 (4.39%) | $293,600,000 (1.28%) | $289,900,000 (0.73%) | $287,800,000 (-16.31%) |
Selling General & Administrative Expense | $318,500,000 (-4.93%) | $335,000,000 (2.60%) | $326,500,000 (14.44%) | $285,300,000 (-14.22%) |
Research & Development Expense | $26,200,000 (-3.68%) | $27,200,000 (-6.85%) | $29,200,000 (-4.58%) | $30,600,000 (-12.32%) |
Operating Expenses | $781,400,000 (115.74%) | $362,200,000 (1.83%) | $355,700,000 (12.60%) | $315,900,000 (-14.04%) |
Interest Expense | $12,200,000 (-18.67%) | $15,000,000 (50.00%) | $10,000,000 (203.03%) | $3,300,000 (-78.85%) |
Income Tax Expense | -$17,000,000 (-950.00%) | $2,000,000 (-61.54%) | $5,200,000 (146.43%) | -$11,200,000 (66.96%) |
Net Loss Income from Discontinued Operations | $5,800,000 (-88.82%) | $51,900,000 (278.97%) | -$29,000,000 (22.04%) | -$37,200,000 (0%) |
Consolidated Income | -$392,100,000 (-534.47%) | -$61,800,000 (-222.38%) | $50,500,000 (701.59%) | $6,300,000 (121.72%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$392,100,000 (-534.47%) | -$61,800,000 (-222.38%) | $50,500,000 (701.59%) | $6,300,000 (121.72%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$392,100,000 (-534.47%) | -$61,800,000 (-222.38%) | $50,500,000 (701.59%) | $6,300,000 (121.72%) |
Weighted Average Shares | $45,956,997 (-1.01%) | $46,425,569 (-0.15%) | $46,497,608 (-3.51%) | $48,186,573 (0.74%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | -$396,900,000 (-785.94%) | -$44,800,000 (-168.19%) | $65,700,000 (4206.25%) | -$1,600,000 (96.62%) |
Gross Profit | $381,300,000 (0.42%) | $379,700,000 (-3.68%) | $394,200,000 (31.75%) | $299,200,000 (-19.33%) |
Operating Income | -$400,100,000 (-2386.29%) | $17,500,000 (-54.55%) | $38,500,000 (330.54%) | -$16,700,000 (-591.18%) |
AVNS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$27,500,000 (-227.31%) | $21,600,000 (115.95%) | -$135,400,000 (-544.76%) | -$21,000,000 (13.22%) |
Net Cash Flow from Financing | -$49,100,000 (47.88%) | -$94,200,000 (-266.14%) | $56,700,000 (202.53%) | -$55,300,000 (21.00%) |
Net Cash Flow from Operations | $100,700,000 (210.80%) | $32,400,000 (-64.36%) | $90,900,000 (4.12%) | $87,300,000 (3592.00%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $20,000,000 (150.00%) | -$40,000,000 (-534.78%) | $9,200,000 (31.43%) | $7,000,000 (107.46%) |
Net Cash Flow - Business Acquisitions and Disposals | $2,100,000 (-94.67%) | $39,400,000 (133.94%) | -$116,100,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$11,800,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$17,800,000 (0.00%) | -$17,800,000 (7.77%) | -$19,300,000 (8.10%) | -$21,000,000 (-3.96%) |
Issuance (Repayment) of Debt Securities | -$33,600,000 (48.07%) | -$64,700,000 (-164.38%) | $100,500,000 (301.00%) | -$50,000,000 (28.37%) |
Issuance (Purchase) of Equity Shares | -$11,700,000 (34.27%) | -$17,800,000 (59.36%) | -$43,800,000 (-726.42%) | -$5,300,000 (-312.00%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$4,100,000 (-2150.00%) | $200,000 (106.67%) | -$3,000,000 (25.00%) | -$4,000,000 (-237.93%) |
Share Based Compensation | $13,800,000 (-12.66%) | $15,800,000 (-0.63%) | $15,900,000 (20.45%) | $13,200,000 (9.09%) |
Depreciation Amortization & Accretion | $45,500,000 (-1.30%) | $46,100,000 (-3.35%) | $47,700,000 (24.54%) | $38,300,000 (-10.72%) |
AVNS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 55.40% (-1.77%) | 56.40% (-2.08%) | 57.60% (12.94%) | 51.00% (-1.73%) |
Profit Margin | -57.00% (-519.57%) | -9.20% (-224.32%) | 7.40% (572.73%) | 1.10% (126.83%) |
EBITDA Margin | -51.10% (-25650.00%) | 0.20% (-98.80%) | 16.60% (163.49%) | 6.30% (1150.00%) |
Return on Average Equity (ROAE) | -34.80% (-596.00%) | -5.00% (-225.00%) | 4.00% (700.00%) | 0.50% (121.74%) |
Return on Average Assets (ROAA) | -25.60% (-611.11%) | -3.60% (-224.14%) | 2.90% (625.00%) | 0.40% (123.53%) |
Return on Sales (ROS) | -57.70% (-761.19%) | -6.70% (-169.79%) | 9.60% (3300.00%) | -0.30% (95.45%) |
Return on Invested Capital (ROIC) | -74.00% (-988.24%) | -6.80% (-174.73%) | 9.10% (4650.00%) | -0.20% (96.88%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.87 (89.02%) | -16.99 (-167.82%) | 25.06 (-90.60%) | 266.69 (454.58%) |
Price to Sales Ratio (P/S) | 1.06 (-31.22%) | 1.55 (-15.88%) | 1.84 (-35.38%) | 2.85 (-7.30%) |
Price to Book Ratio (P/B) | 0.88 (4.87%) | 0.84 (-13.55%) | 0.97 (-25.93%) | 1.31 (-24.73%) |
Debt to Equity Ratio (D/E) | 0.39 (6.50%) | 0.37 (-3.91%) | 0.38 (46.56%) | 0.26 (-20.85%) |
Earnings Per Share (EPS) | -8.53 (-546.21%) | -1.32 (-222.22%) | 1.08 (730.77%) | 0.13 (121.31%) |
Sales Per Share (SPS) | 14.97 (3.19%) | 14.5 (-1.43%) | 14.71 (20.78%) | 12.18 (-18.48%) |
Free Cash Flow Per Share (FCFPS) | 1.8 (474.52%) | 0.31 (-79.61%) | 1.54 (11.92%) | 1.38 (389.68%) |
Book Value Per Share (BVPS) | 18.03 (-32.30%) | 26.63 (-4.10%) | 27.77 (5.31%) | 26.37 (0.38%) |
Tangible Assets Book Value Per Share (TABVPS) | 12.76 (-9.82%) | 14.15 (-16.99%) | 17.04 (24.28%) | 13.71 (-7.95%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (92.86%) | -28 (-227.27%) | 22 (101.98%) | -1,112 (-2169.39%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.4 (-100.25%) | 954.56 (7389.08%) | 12.75 (-73.70%) | 48.46 (109.13%) |
Asset Turnover | 0.45 (13.67%) | 0.4 (2.33%) | 0.39 (7.52%) | 0.36 (-12.22%) |
Current Ratio | 2.37 (14.21%) | 2.08 (-36.47%) | 3.27 (6.38%) | 3.07 (9.36%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | $82,900,000 (467.81%) | $14,600,000 (-79.61%) | $71,600,000 (7.99%) | $66,300,000 (392.07%) |
Enterprise Value (EV) | $844,835,392 (-31.92%) | $1,240,925,513 (-14.15%) | $1,445,425,272 (-18.73%) | $1,778,628,486 (-23.82%) |
Earnings Before Tax (EBT) | -$409,100,000 (-584.11%) | -$59,800,000 (-207.36%) | $55,700,000 (1236.73%) | -$4,900,000 (92.21%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$351,400,000 (-27130.77%) | $1,300,000 (-98.85%) | $113,400,000 (208.99%) | $36,700,000 (934.09%) |
Invested Capital | $482,900,000 (-11.17%) | $543,600,000 (-27.59%) | $750,700,000 (27.11%) | $590,600,000 (-13.60%) |
Working Capital | $227,500,000 (-9.87%) | $252,400,000 (-41.72%) | $433,100,000 (50.17%) | $288,400,000 (-4.15%) |
Tangible Asset Value | $586,300,000 (-10.73%) | $656,800,000 (-17.11%) | $792,400,000 (19.92%) | $660,800,000 (-7.27%) |
Market Capitalization | $731,635,392 (-29.74%) | $1,041,325,513 (-17.24%) | $1,258,225,272 (-24.69%) | $1,670,628,486 (-23.87%) |
Average Equity | $1,127,025,000 (-9.69%) | $1,247,975,000 (-1.40%) | $1,265,700,000 (-0.37%) | $1,270,350,000 (0.33%) |
Average Assets | $1,532,375,000 (-10.11%) | $1,704,725,000 (-3.71%) | $1,770,350,000 (8.38%) | $1,633,400,000 (-6.55%) |
Invested Capital Average | $536,650,000 (-18.28%) | $656,675,000 (-9.45%) | $725,200,000 (11.60%) | $649,800,000 (-11.71%) |
Shares | 45,956,997 (-1.01%) | 46,425,569 (-0.15%) | 46,497,608 (-3.51%) | 48,186,573 (0.74%) |